CO-IRBEK® is an antihypertensive angiotensin receptor antagonist (ARA II), indicated in the treatment of essential hypertension, also in renal impairment in hypertensive patients with type 2 diabetes.
| DCI | IRBESARTAN / HCTZ |
|---|---|
| Dosage | 150/12.5 mg |
| Trade name | CO-IRBEK® |
| Name of the originator | Co Aprovel |
| Presentation | 30 tablets |
| Specialty | Cardiologie – Sartans |
